CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tianjin Lisheng Pharmaceutical Company Limited Company Snapshot
Tianjin Lisheng Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Lisheng Pharmaceutical Company Limited with three other companies in this sector in China: Ginwa Enterprise Group Inc. (2015 sales of 727.82 million Chinese Renmimbi [US$104.90 million] of which 52% was Pharmaceutical Industry), Hybio Pharmaceutical Co Ltd (768.26 million Chinese Renmimbi [US$110.73 million] of which 100% was Medical and Pharmaceutical Manufacturing), and Changzhou Qianhong Biopharma Co., Ltd. (757.02 million Chinese Renmimbi [US$109.11 million] of which 100% was Bio-pharmaceutical Industry).

Sales Analysis. During the year ended December of 2015, sales at Tianjin Lisheng Pharmaceutical Company Limited were 774.67 million Chinese Renmimbi (US$111.65 million). This is a very small increase of 0.1% versus 2014, when the company's sales were 773.60 million Chinese Renmimbi. Despite this increase, sales are still well below the level achieved in 2013, when Tianjin Lisheng Pharmaceutical Company Limited reported sales of 1.04 billion Chinese Renmimbi. The sales level in 2015 was fairly close to the level five years ago: in 2010, Tianjin Lisheng Pharmaceutical Company Limited had sales of 737.97 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tianjin Lisheng Pharmaceutical Company Limited
  Stock Performance Chart for Tianjin Lisheng Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 40.47
(Figures in Chinese Renmimbi)
1 Week -2.0%   13 Weeks -4.4%  
4 Weeks 3.8%   52 Weeks 12.3%  
 
Tianjin Lisheng Pharmaceutical Company Limited Key Data:
  Ticker: 002393 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 774,671,139
(Year Ending Jan 2016).
Employees: 1,861
  Currency: Chinese Renmimbi Market Cap: 7,383,953,526
  Fiscal Yr Ends: December Shares Outstanding: 182,454,992
  Share Type: A Gu Closely Held Shares: 103,910,361
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.